Acute Myeloid Leukemia | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …

Umbilical cord blood is an alternative hematopoietic stem cell source for patients with
hematologic diseases who can be cured by allogeneic hematopoietic cell transplantation …

Results of 2 parallel phase 2 trials of transplantation of unrelated umbilical cord blood (UCB)
or bone marrow (BM) from HLA-haploidentical relatives provided equipoise for direct …

Background The majority of patients in need of a hematopoietic-cell transplant do not have a
matched related donor. Data are needed to inform the choice among various alternative …

Abstract Approximately 20,000 hematopoietic cell transplantation (HCT) procedures are
performed in the United States annually. With advances in transplantation technology and …

This is the sixth special report that the European Society for Blood and Marrow
Transplantation regularly publishes on the current practice and indications for …

The success of allogeneic hematopoietic cell transplantation (HCT) is typically assessed as
individual complications, including graft-versus-host disease (GVHD), relapse, or death, yet …

Purpose The major causes of mortality after allogeneic hematopoietic-cell transplantation
(allo-HCT) are relapse, graft-versus-host disease (GVHD), and infection. We have reported …

The small number of hematopoietic stem and progenitor cells in cord blood units limits their
widespread use in human transplant protocols. We identified a family of chemically related …

During mouse cytomegalovirus (CMV) infection, a population of Ly49H+ natural killer (NK)
cells expands and is responsible for disease clearance through the induction of a “memory …